TG Therapeutics | TGTX - Market Capitalization



TG Therapeutics reported $4.92B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Alaunos Therapeutics USD 3M 2M Dec/2024
Amgen USD 150.13B 17.37B Jun/2025
Ardelyx USD 1.51B 568M Sep/2025
Arrowhead Research USD 2.18B 433M Jun/2025
Bayer EUR 25.09B 3.38B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
Corcept Therapeutics USD 7.78B 4.27B Jun/2025
Dynavax Technologies USD 1.19B 421M Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
PTC Therapeutics USD 3.87B 148M Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
TG Therapeutics USD 5.71B 526M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025